Observational Study to Assess the Efficacy and Safety of NovoRapid™ Flexpen™

CompletedOBSERVATIONAL

Enrollment

373

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2Delivery Systems

Interventions

DRUG

insulin aspart

Start dose and frequency to be prescribed by the physician as a result of the normal clinical evaluation

Trial Locations (1)

Novo Nordisk Investigational Site, Manila